Chelsea Close In On Maxence Lacroix As Crystal Palace Defender Reportedly Travels For Medical
Chelsea appear to be closing in on another significant addition to their defensive options, with Crystal Palace centre-back Maxence Lacroix reportedly set to undergo a medical ahead of a move to Stamford Bridge.
According to The Athletic, the final details of an agreement between the clubs are being completed, with the transfer expected to be worth around £52 million. The report adds that Lacroix is expected to sign a long-term contract running until June 2032.
While neither Chelsea nor Crystal Palace have officially announced the deal, the move appears to have reached its final stages if the reported medical proceeds as planned.
Lacroix, 26, joined Crystal Palace after establishing himself as one of the Bundesliga's most athletic defenders during his time with Wolfsburg. Since arriving in the Premier League, he has continued to build a reputation as an aggressive front-foot defender capable of covering large spaces and contributing in possession.
Should the transfer be completed, Chelsea would be adding another defender entering what is widely regarded as his peak years. The proposed seven-year contract would also fit the club's recent recruitment strategy of securing players on lengthy deals.
Although the reported transfer fee reflects Chelsea's belief in Lacroix's qualities, the final figures and payment structure have not been officially confirmed. Likewise, the clubs have yet to publish any formal statement regarding the transfer.
For Crystal Palace, losing a first-team centre-back would represent another significant defensive reshuffle. Any departure would likely require planning within the remainder of the transfer window, although there has been no official indication from the club regarding a replacement.
From Chelsea's perspective, strengthening central defence would provide additional depth across domestic and European competitions. Squad competition has become increasingly important given the demands of a long season, and another experienced option could offer greater tactical flexibility.
The timing of the reported medical suggests negotiations are well advanced, but transfers can still encounter late complications until contracts are signed and all regulatory requirements have been completed. As a result, the move should still be treated as pending until official confirmation arrives from the clubs involved.
